STUB1 and myelodysplastic syndrome: The traditional understanding that the presence of higher VAF levels at diagnosis has been implicated to be the early acquired somatic clones in MDS or AML, and therefore CHIP mutations have been proven to be one of the earliest events in the pathogenesis of these myeloid neoplasms.